WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03C ADRENERGICS FOR SYSTEMIC USE

This group comprises adrenergics for systemic use indicated for e.g. bronchial asthma. Sympathomimetics used in the treatment of hypotension, see C01CA. Fenoterol infusion only intended for repression of labour is classified in G02CA.
Combinations with xanthines are classified in R03DB. Combinations with other drugs for obstructive airway diseases belonging to R03D excl. xanthines are classified in R03CK.


R03CA Alpha- and beta-adrenoreceptor agonists

Ephedrine injections are classified in C01CA.

R03CB Non-selective beta-adrenoreceptor agonists

Isoprenaline for systemic use is classified in this group only if bronchial asthma is the only indication for the preparation, otherwise in
C01C - Cardiac stimulants excl. cardiac glycosides.

R03CC Selective beta-2-adrenoreceptor agonists
R03CK Adrenergics and other drugs for obstructive airway diseases

Combinations of adrenergics with other drugs for obstructive airway diseases belonging to R03D (excl. xanthines, see R03DB) are classified here.

Last updated: 2024-01-26